tetano
Editor, Senior Moderator
Infect Dis Clin North Am
. 2023 Mar 21;S0891-5520(23)00024-7.
doi: 10.1016/j.idc.2023.03.003. Online ahead of print. Coronavirus Disease 2019 Management Strategies in Solid Organ Transplant Recipients
Maria Alejandra Mendoza[SUP] 1 [/SUP], Raymund R Razonable[SUP] 2 [/SUP]
Affiliations
Solid organ transplant recipients are at high risk of severe coronavirus disease-2019 (COVID-19). If left untreated, it results in high rates of hospitalization, intensive care unit admission and death. Early diagnosis of COVID-19 is essential to ensure the early administration of therapeutics. Treatment of mild-to-moderate COVID-19 with remdesivir, ritonavir-boosted nirmatrelvir, or an anti-spike neutralizing monoclonal antibody may prevent progression to severe and critical COVID-19. Among patients with severe and critical COVID-19, treatment with intravenous remdesivir and immunomodulation is recommended. This review article discusses strategies in the management of solid organ transplant recipients with COVID-19.
Keywords: Anti-spike monoclonal antibodies; COVID-19; Coronavirus disease-2019; Molnupiravir; Nirmatrelvir; Remdesivir; Transplantation.
. 2023 Mar 21;S0891-5520(23)00024-7.
doi: 10.1016/j.idc.2023.03.003. Online ahead of print. Coronavirus Disease 2019 Management Strategies in Solid Organ Transplant Recipients
Maria Alejandra Mendoza[SUP] 1 [/SUP], Raymund R Razonable[SUP] 2 [/SUP]
Affiliations
- PMID: 37142512
- DOI: 10.1016/j.idc.2023.03.003
Solid organ transplant recipients are at high risk of severe coronavirus disease-2019 (COVID-19). If left untreated, it results in high rates of hospitalization, intensive care unit admission and death. Early diagnosis of COVID-19 is essential to ensure the early administration of therapeutics. Treatment of mild-to-moderate COVID-19 with remdesivir, ritonavir-boosted nirmatrelvir, or an anti-spike neutralizing monoclonal antibody may prevent progression to severe and critical COVID-19. Among patients with severe and critical COVID-19, treatment with intravenous remdesivir and immunomodulation is recommended. This review article discusses strategies in the management of solid organ transplant recipients with COVID-19.
Keywords: Anti-spike monoclonal antibodies; COVID-19; Coronavirus disease-2019; Molnupiravir; Nirmatrelvir; Remdesivir; Transplantation.